NAD+ injections or IV therapy are used to boost cellular energy, support brain function, enhance metabolism, and promote anti-aging benefits by replenishing declining NAD+ levels.
Methylene Blue is used in medicine to treat methemoglobinemia (a blood disorder that reduces oxygen delivery) and is being studied for its potential benefits in cognitive support, mitochondrial health, and antimicrobial activity.
Semaglutide/Glycine is an injectable therapy designed to promote weight loss and improve blood sugar control, with glycine added to support stability and injection comfort.
Tirzepatide/Glycine is an injectable medication that aids in weight loss and blood sugar control by enhancing insulin sensitivity, suppressing appetite, and slowing digestion, with glycine included to improve tolerance and potential metabolic support.
